A prospective, multi-center, single-arm, open phase Ib clinical study of safety, tolerability and preliminary efficacy of anlotinib combined with duvalizumab in patients with advanced gastric or colorectal cancer who have failed second-line treatment

ABSTRACT: Interventions: experimental group:Anlotinib combined with Duvalizumab Primary outcome(s): DLT Study Design: Single arm

DISEASE(S): Advanced Colorectal Cancer Or Stomach Cancer

PROVIDER: 2699928 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR